UK remote
Associate Director, Market Access and HTA, UK and Ireland
About this role
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients. The Opportunity: The Associate Director, Market Access and HTA, is responsible for leading end-to-end reimbursement activities to ensure timely, sustainable patient access to innovative oncology therapies. Working closely with the Senior Director, Market Access, this role involves delivering high-quality HTA submissions (NICE, SMC, NCPE), supporting the development of Market Access strategies, core pricing and access deliverables, and guiding evidence generation to support value propositions.
The incumbent will partner with global, regional, and local cross functional colleagues, spanning market access, commercial, medical affairs, HEOR and vendor partners on all reimbursement activities by providing access insights, developing evidence-based HTA dossiers and tools, as well as participating in pricing strategy activities. HTA Strategy and Delivery Lead HTA submissions to NICE, SMC, and NCPE from initiation to final recommendation, managing timelines and deliverables.
Lead engagement with HTA agencies throughout the reimbursement process. Source, interpret and generate clinical and economic evidence to support robust submissions. Partner with regional and global HEOR teams to support the design and development of health economic models; manage technical vendors as required. Communicate complex economic concepts clearly to both technical and non technical audiences. Provide expertise on RWE studies, economic modelling, evidence synthesis (SLRs, NMAs, ITCs), and pricing activities.